TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Neupath Health Inc. ( (TSE:NPTH) ) just unveiled an announcement.
NeuPath Health Inc. reported record first-quarter revenue of $19.3 million, an 11% increase from the previous year, and a 49% rise in adjusted EBITDA to $1.3 million. The company secured new credit facilities to support growth and refinance debt, and appointed Stephen Lemieux as President to lead strategic initiatives. The improved financial performance was driven by organic growth in Alberta and Ontario, better clinic space utilization, and positive adjustments to physician reimbursement rates. NeuPath anticipates further growth and a potentially significant one-time payment in Q2 2025, enhancing its market position and operational capabilities.
More about Neupath Health Inc.
NeuPath Health Inc. operates a network of clinics specializing in chronic pain treatment, with a focus on delivering medical services in Alberta and Ontario, Canada. The company also provides physician staffing for correctional institutions and conducts contract research services for pharmaceutical companies.
Average Trading Volume: 77,681
Technical Sentiment Signal: Buy
Current Market Cap: C$12.05M
See more insights into NPTH stock on TipRanks’ Stock Analysis page.